Silanes and Galenicum Health launch dexketoprofen in Mexico

February 2, 2018

This week, Silanes (Mexican pharmaceutical laboratory) together with Galenicum Health, have launched in Mexico dexketoprofen 25mg oral solution.

Our international team participated in the launch meeting, which had an attendance of around 300 people. The ambition of Silanes is "to be the best pharmaceutical launch of 2018 in Mexico".

Dexketoprofen is indicated for the symptomatic treatment of pain of mild or moderate intensity, such as musculoskeletal pain, dysmenorrhea and toothache. Being in the form of an oral solution, it has the advantage that its absorption (and therefore the rate of onset of action) is around 15 minutes, versus 30 minutes of the tablets.

With this product, Galenicum Health plans to manufacture 30 million units (1.7 million packs) in 2018. Therefore, it means for both laboratories a launch of great relevance for this new year.


Sergio Malagrida, International Head at Galenicum Health